Literature DB >> 36152168

Automatic segmentation of prostate and extracapsular structures in MRI to predict needle deflection in percutaneous prostate intervention.

Franklin King1, Nobuhiko Hata1, Satoshi Kobayashi2,3.   

Abstract

PURPOSE: Understanding the three-dimensional anatomy of percutaneous intervention in prostate cancer is essential to avoid complications. Recently, attempts have been made to use machine learning to automate the segmentation of functional structures such as the prostate gland, rectum, and bladder. However, a paucity of material is available to segment extracapsular structures that are known to cause needle deflection during percutaneous interventions. This research aims to explore the feasibility of the automatic segmentation of prostate and extracapsular structures to predict needle deflection.
METHODS: Using pelvic magnetic resonance imagings (MRIs), 3D U-Net was trained and optimized for the prostate and extracapsular structures (bladder, rectum, pubic bone, pelvic diaphragm muscle, bulbospongiosus muscle, bull of the penis, ischiocavernosus muscle, crus of the penis, transverse perineal muscle, obturator internus muscle, and seminal vesicle). The segmentation accuracy was validated by putting intra-procedural MRIs into the 3D U-Net to segment the prostate and extracapsular structures in the image. Then, the segmented structures were used to predict deflected needle path in in-bore MRI-guided biopsy using a model-based approach.
RESULTS: The 3D U-Net yielded Dice scores to parenchymal organs (0.61-0.83), such as prostate, bladder, rectum, bulb of the penis, crus of the penis, but lower in muscle structures (0.03-0.31), except and obturator internus muscle (0.71). The 3D U-Net showed higher Dice scores for functional structures ([Formula: see text]0.001) and complication-related structures ([Formula: see text]0.001). The segmentation of extracapsular anatomies helped to predict the deflected needle path in MRI-guided prostate interventions of the prostate with the accuracy of 0.9 to 4.9 mm.
CONCLUSION: Our segmentation method using 3D U-Net provided an accurate anatomical understanding of the prostate and extracapsular structures. In addition, our method was suitable for segmenting functional and complication-related structures. Finally, 3D images of the prostate and extracapsular structures could simulate the needle pathway to predict needle deflections.
© 2022. CARS.

Entities:  

Keywords:  3D U-Net; Deep learning; Percutaneous intervention; Prostate; Segmentation

Year:  2022        PMID: 36152168     DOI: 10.1007/s11548-022-02757-2

Source DB:  PubMed          Journal:  Int J Comput Assist Radiol Surg        ISSN: 1861-6410            Impact factor:   3.421


  23 in total

1.  3D Slicer as an image computing platform for the Quantitative Imaging Network.

Authors:  Andriy Fedorov; Reinhard Beichel; Jayashree Kalpathy-Cramer; Julien Finet; Jean-Christophe Fillion-Robin; Sonia Pujol; Christian Bauer; Dominique Jennings; Fiona Fennessy; Milan Sonka; John Buatti; Stephen Aylward; James V Miller; Steve Pieper; Ron Kikinis
Journal:  Magn Reson Imaging       Date:  2012-07-06       Impact factor: 2.546

2.  Oncologic and Functional Outcomes of Partial Gland Ablation with High Intensity Focused Ultrasound for Localized Prostate Cancer.

Authors:  Roman Bass; Neil Fleshner; Antonio Finelli; Jack Barkin; Liying Zhang; Laurence Klotz
Journal:  J Urol       Date:  2019-01       Impact factor: 7.450

3.  A comparison of prostate tumor targeting strategies using magnetic resonance imaging-targeted, transrectal ultrasound-guided fusion biopsy.

Authors:  Peter R Martin; Derek W Cool; Aaron Fenster; Aaron D Ward
Journal:  Med Phys       Date:  2018-02-16       Impact factor: 4.071

4.  Deeply supervised 3D fully convolutional networks with group dilated convolution for automatic MRI prostate segmentation.

Authors:  Bo Wang; Yang Lei; Sibo Tian; Tonghe Wang; Yingzi Liu; Pretesh Patel; Ashesh B Jani; Hui Mao; Walter J Curran; Tian Liu; Xiaofeng Yang
Journal:  Med Phys       Date:  2019-02-19       Impact factor: 4.071

5.  Focal Therapy in Primary Localised Prostate Cancer: The European Association of Urology Position in 2018.

Authors:  Henk G van der Poel; Roderick C N van den Bergh; Erik Briers; Philip Cornford; Alex Govorov; Ann M Henry; Thomas B Lam; Malcolm D Mason; Olivier Rouvière; Maria De Santis; Peter-Paul M Willemse; Hendrik van Poppel; Nicolas Mottet
Journal:  Eur Urol       Date:  2018-01-17       Impact factor: 20.096

6.  Needle deflection and tissue sampling length in needle biopsy.

Authors:  Annie D R Li; Jeffrey Plott; Lei Chen; Jeffrey S Montgomery; Albert Shih
Journal:  J Mech Behav Biomed Mater       Date:  2020-01-11

7.  MRI-Guided Robotically Assisted Focal Laser Ablation of the Prostate Using Canine Cadavers.

Authors:  Yue Chen; Sheng Xu; Alexander Squires; Reza Seifabadi; Ismail Baris Turkbey; Peter A Pinto; Peter Choyke; Bradford Wood; Zion Tsz Ho Tse
Journal:  IEEE Trans Biomed Eng       Date:  2017-09-26       Impact factor: 4.538

8.  Transperineal in-bore 3-T MR imaging-guided prostate biopsy: a prospective clinical observational study.

Authors:  Tobias Penzkofer; Kemal Tuncali; Andriy Fedorov; Sang-Eun Song; Junichi Tokuda; Fiona M Fennessy; Mark G Vangel; Adam S Kibel; Robert V Mulkern; William M Wells; Nobuhiko Hata; Clare M C Tempany
Journal:  Radiology       Date:  2014-09-15       Impact factor: 11.105

9.  Evaluation of robot-assisted MRI-guided prostate biopsy: needle path analysis during clinical trials.

Authors:  Pedro Moreira; Niravkumar Patel; Marek Wartenberg; Gang Li; Kemal Tuncali; Tamas Heffter; Everette C Burdette; Iulian Iordachita; Gregory S Fischer; Nobuhiko Hata; Clare M Tempany; Junichi Tokuda
Journal:  Phys Med Biol       Date:  2018-10-16       Impact factor: 3.609

10.  Propensity-weighted long-term risk of urinary adverse events after prostate cancer surgery, radiation, or both.

Authors:  Stephanie L Jarosek; Beth A Virnig; Haitao Chu; Sean P Elliott
Journal:  Eur Urol       Date:  2014-09-10       Impact factor: 20.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.